NIIN Output Data
NIIN:
NSN:
Item Name:
ESMOLOL HYDROCHLORIDE INJECTION
Definition:
Reference/Part Number
Part Number | CAGE | Status | RNCC | RNVC | DAC | RNAAC | MSDS | SADC |
---|---|---|---|---|---|---|---|---|
NDC63323-0652-10 | 4JRB5 | A | 3 | 2 | 4 | ZZ | ||
NDC63323-0652-10 | 3K7Y8 | A | 3 | 2 | 4 | ZZ | ||
NDC00641-2965-45 | 4LQT5 | A | 5 | 2 | 4 | ZZ | ||
BREVIBLOC | 3D203 | F | 5 | 9 | 4 | ZZ | ||
NDC00641-2965-45 | 12073 | H | 5 | 9 | 4 | ZZ | ||
NDC10019-0155-01 | 3D203 | F | 5 | 9 | 4 | ZZ | ||
02-2786 | 89875 | A | 5 | 1 | 4 | ZZ |
CAGE Information
Code | Company |
---|---|
12073 | BAXTER HEALTHCARE CORP BAXTER PHARMA |
4JRB5 | APP PHARMACEUTICALS INC. |
3K7Y8 | ABRAXIS L.L.C. |
4LQT5 | VETERANS HEALTH |
3D203 | BAXTER HEALTHCARE CORP BAXTER HOSPIT |
89875 | DEFENSE LOGISTICS AGENCY DIRECTORATE |
Federal Supply Class
Title
DRUGS AND BIOLOGICALS
Inclusions:
INCLUDES ALL DRUGS, MEDICINAL GRADE CHEMICALS, AND BIOLOGICALS SUBJECT TO THE FEDERAL FOOD, DRUG AND COSMETIC ACT, LISTED IN THE MONOGRAPH SECTION OF THE U.S. PHARMACOPEIA OR THE NATIONAL FORMULARY OR COVERED BY THE UNITED STATES ADOPTED NAMES (USAN). OTHER NATIONS MAY APPLY THEIR OWN LEGAL DOCUMENTS.
Exclusions:
EXCLUDES MEDICATED COSMETICS AND TOILETRIES CLASSIFIABLE IN FSC 6508 AND IN VITRO DIAGNOSTIC SUBSTANCES AND REAGENTS CLASSIFIABLE IN FSC 6550, AND VETERINARY DRUGS AND BIOLOGICALS CLASSIFIABLE IN FSC 6509.
Characteristics (Decoded)
MRC | Requirements Statement | Clear Text Reply |
---|---|---|
CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | BREVIBLOC INJECTION IV VI 10 ML STER 25S |
CBBL | FEATURES PROVIDED | STERILE |
AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 10.000 KILOGRAMS PER CUBIC DECIMETER ESMOLOL HYDROCHLORIDE PER MILLILITER |
CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 25 |
AJUC | AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER | 240400 |
FEAT | SPECIAL FEATURES | INDICATED FOR THE RAPID CONTROL OF VENTRICULAR RATE IN PATIENTS WITH ATRIAL FIBRILLATION OR ATRIAL FLUTTER IN THE PERIOPERATIVE, POSTOPERATIVE OR OTHER EMERGENT CIRCUMSTANCES WHEN SHORT-TERM CONTROL OF VENTRICULAR RATE WITH A SHORT-ACTING AGENT IS DESIRABLE |
CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 10.000 MILLILITERS |
AJCN | PROTECTIVE STORAGE FEATURE | SUBJECT TO DAMAGE BY FREEZING |
CQCT | PRIMARY CONTAINER TYPE | VIAL, SINGLE DOSE |
CSGS | ADMINISTRATION | INTRAVENOUS |